ODC1 and neuroblastoma: In this regard, Michael et al., provided evidence that the expansion of polyamines via the broad deregulation of regulatory enzymes, including ODC1, was a defining characteristic of neuroblastomas exhibiting MYCN amplification, and they identified a strong correlation between elevated levels of ODC1 and unfavorable clinical outcomes in a large patient cohort, including those without MYCN amplification [93].